Jenoptik
JEN.DE Mid CapTechnology · Electronic Components
Mis à jour: Aug 2, 2026, 22:14 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Jenoptik en bref
Jenoptik (JEN.DE) is currently trading at 37,28 € with a market capitalization of 1,9 Md €. The trailing P/E ratio stands at 28.03x, with a forward P/E of 16.18x. The 52-week range spans from 16,04 € to 48,42 €; the current price is 23% below the yearly high. Year-over-year revenue growth stands at -1.0%. The net profit margin stands at 7.61%.
💰 Dividende
Jenoptik pays an annual dividend of 0,40 € per share, representing a yield of 1.07%. The payout ratio stands at 28.57%.
📊 Avis des analystes
8 analystes évaluent Jenoptik (JEN.DE) au consensus : Acheter. L'objectif de cours moyen est de 44,69 €, soit un potentiel de +19.87% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 29,50 € à 55,00 €.
Jenoptik : la thèse d'investissement en détail
Jenoptik (JEN.DE) operates in the Technology — specifically Electronic Components — and is headquartered in Germany. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Earnings growth of 81.3% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Wall Street consensus sits at Buy with an average price target implying roughly 19.87% upside from current levels — analyst sentiment is firmly constructive.
Le scénario baissier
Revenue is contracting at -1% year-over-year — until that trend reverses, valuation is exposed to further downgrades.
Valorisation en contexte
The PEG ratio at 1.13 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.
À surveiller
- The forward P/E of 16.18x is meaningfully below the trailing 28.03x — analysts expect earnings to step up; the next earnings release is the test.
Thèse d'investissement : forces et faiblesses
- Consensus des analystes : Buy
- Bilan solide avec faible endettement (D/E 38.25)
- Free cash flow positif
- –CA en contraction (-1% sur un an)
Aperçu technique
Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).
Profil de risque
The data points to market-like volatility.
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
More Technologie stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Jenoptik?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
